Given lingering exclusivity around once-weekly semaglutide and tirzepatide until at least 2031, the GLP-1 agonists industry will likely remain a duopoly in premium markets, with incremental erosion from value-tier competition rather than disruptive share shifts
It works upstream of all that at the level of desire and motivation in the brain
The results from the treatment have been great, and the whole experience was calm and professional
Monitor the whole patient Psychiatric stability and medication adherence Sleep, cognition, energy and exercise tolerance Weight, glucose, lipids and blood pressure Repeat biomarkers only when they will change treatment Methylene blue, peptides and experimental agents: these are treatment-specific topics rather than the foundation of mitochondrial care
We first reasoned that changes in DHODH activity were responsible for buffering this imbalance